Harvard Bioscience (HBIO) Current Deferred Tax Assets (2010 - 2015)

Harvard Bioscience (HBIO) has 6 years of Current Deferred Tax Assets data on file, last reported at $42000.0 in Q4 2015.

• Current Deferred Tax Assets for Q4 2015 came in at $42000.0, down 97.23% year-over-year; the trailing twelve-month figure through Dec 2015 was $42000.0 (down 97.23% YoY), and the FY2015 annual result was $42000.0, down 97.23% from the prior year.
• Current Deferred Tax Assets retreated to $42000.0 in Q4 2015 per HBIO's latest filing, from $2.6 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $5.7 million in Q3 2011 and troughed at $42000.0 in Q4 2015.
• A 5-year average of $2.5 million and a median of $1.6 million in 2013 frame the typical range for Current Deferred Tax Assets.
• On a YoY basis, Current Deferred Tax Assets climbed as much as 68.8% in 2015 and fell as far as 97.23% in 2015.
• A 5-year view of Current Deferred Tax Assets shows it stood at $3.9 million in 2011, then plunged by 60.26% to $1.6 million in 2012, then dropped by 0.39% to $1.5 million in 2013, then declined by 2.07% to $1.5 million in 2014, then plunged by 97.23% to $42000.0 in 2015.
• Business Quant data shows HBIO's Current Deferred Tax Assets at $42000.0 in Q4 2015, $2.6 million in Q3 2015, and $2.6 million in Q2 2015.